Upper Extremity Elevation and Lungfunction After Open Heart Surgery

Heart Diseases Clinical Trial

Official title:

Effects of Upper Extremity Elevation and Deep Breathing on Oxygen Saturation and Lung Volume Two to Four Days After Open Heart Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05278819
• Other study ID #: 278090
• Status: Completed
• Phase: N/A
• Start date: April 1, 2022
• Est. completion date: June 6, 2022

Study information

• Verified date: November 2023
• Source: Region Örebro County
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to assess if arm elevation, with or without simultaneous deep breathing, affects oxygen saturation and lung function on patients two to four days after open heart surgery.

Description:

This single center, interventional crossover study will involve patients day 2, 3 or 4 after open heart surgery. Patients who meet the eligibility requirements will be informed about the study and potential risks, given a written informed consent they will be included for intervention being held later on the same day. Randomization will be given to the investigator in a sealed envelope and being opened after base line measurements. Data will then be collected for the randomized intervention and after a wash out period (several minutes) again for the crossover intervention.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 22
• Est. completion date: June 6, 2022
• Est. primary completion date: June 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• open heart surgery at university hospital in Örebro

Exclusion Criteria:

• not able to communicate in swedish

• difficulties in cooperating during measurements

• cognitive impairement

• prolonged stay at ICU (still at ICU on the day of investigation)

• ongoing oxygen treatment with more than 5 liter/minut (FiO > 40 %)

Related Conditions & MeSH terms

• Heart Diseases
• Heart Diseases, Ischemic
• Heart Valve Diseases
• Myocardial Ischemia

Intervention

Other:
• upper extremity elevation
5 repetitions of active upper extremity elevation in a sitting position
• upper extremity elevation with deep breathing
5 repetitions of active upper extremity elevation with deep breathing in a sitting position

Locations

Country	Name	City	State
Sweden	University Hospital	Örebro

Sponsors (4)

Lead Sponsor	Collaborator
Michael Reinhart	Linkoeping University, Örebro University, Sweden, Region Örebro County

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	peripheral oxygen saturation		30 minutes
Secondary	tidal volume		30 minutes
Secondary	heart rate		30 minutes
Secondary	respiratory rate		30 minutes
Secondary	pain - numeric rating scale	Pain (sternal, thorax or overall pain) will be measured before and after intervention, NRS will be used (patient rating of perceived pain with a score from 0 to 10)	30 minutes
Secondary	dyspnea - numeric rating scale	Dyspnea will be measured before and after intervention, NRS will be used (patient rating of perceived dyspnea with a score from 0 to 10)	30 minutes
Secondary	exertion - numeric rating scale	exertion will be measured before and after intervention, NRS will be used (patient rating of perceived exertion with a score from 0 to 10)	30 minutes